UNSPSC 51291712: Venlafaxine hydrochloride

This classification denotes an antidepressant agent with the molecular formula C17H27NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7D7RX5A8MO, chemically known as wy-45,030 but more generally known as venlafaxine hcl, which bears US NIH Compound Identifier 62923. European Medicines Agency schedules Venlafaxine hcl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05087MIG. Most nations, for tariff and trade purposes, schedule venlafaxine hydrochloride under HS 29225000 and SITC 51467.

As of Q4 2014, VENLAFAXINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Venlafaxine hydrochloride bears US NLM identifiers UMLS ID C0771200 and NCI Concept Code C29540. SMILES: CN(C)CC(C1CCC(CC1)OC)C2(CCCCC2)O.CL.

UNSPSC 51291712 Venlafaxine hydrochloride is a Commodity code that captures pharmaceutical products procured by state and local health agencies, though recent solicitation activity under this specific code shows a significant mismatch with the nominal product scope. The recent opportunity record tagged to this code documents Seminole County, Florida's procurement of naloxone and drug deactivation systems—products unrelated to venlafaxine, an antidepressant medication. This mismatch suggests either a classification error in the source data or that the code is being used as a catch-all for pharmaceutical and medical supply purchases by county health departments rather than for venlafaxine specifically. State and local procurement under pharmaceutical commodity codes typically involves health departments, county community health agencies, and public health authorities sourcing medications, medical devices, and allied health products through IFB, RFQ, and cooperative purchasing agreements.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid deadline was July 26, 2023 (a historical date relative to the posting). The procurement required vendors to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The contract offered an initial two-year term with a one-year renewal option and was potentially FEMA-funded, introducing federal compliance requirements. The source supports no additional recent opportunities under this code; the single record is the only documented activity and appears misclassified relative to the code's venlafaxine scope.